Observation study of myotonic dystrophy over 24 months
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study is following people with myotonic dystrophy over 24 months to better understand the disease by combining past medical records already in a registry with new check-ups. It doesn't test a new treatment but helps researchers learn about the condition, which may lead to better care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic test confirming myotonic dystrophy type 1 or 2.
- You are already enrolled in the DM-Scope registry.
- You are 18 years or older.
- Your body mass index (BMI) is between 18.5 and 30, and you weigh at least 45 kg.
- You have symptoms of myotonia (muscles that have trouble relaxing).
- If you have DM1, your muscle impairment is at a moderate level (score 2, 3, or 4 on a scale).
- You can walk 10 meters independently with or without aids.
- You have not taken mexiletine in the last 18 months.
- You don't have other conditions that severely affect hand or walking function (like severe arthritis or hand deformities).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a long-term follow-up for people with myotonic dystrophy type 1. It aims to find better ways to measure how the disease progresses, which could help develop future treatments.
This study follows people with myotonic dystrophy type 1 (DM1) over time to learn more about how the disease progresses. It collects health information and samples to help improve care.
This study measures physical and lab “health markers” in people with myotonic dystrophy type 1 (DM1) to better understand how the disease changes over time. Some participants may also have a muscle biopsy to study tissue differences.
This study builds a registry of people and families affected by myotonic dystrophy types 1 and 2. It helps researchers learn about the condition over time and may support future studies that could lead to better care.
This study tests if a structured exercise program is safe and helpful for people with myotonic dystrophy type 2 (DM2). It aims to improve strength and daily function.
This study uses MRI scans to measure muscle changes in people with myotonic dystrophy (DM1 or DM2) and healthy volunteers. The goal is to find better ways to track the disease over time.
Hear when a new Myotonic Dystrophy 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.